CureVac(CVAC)
搜索文档
CureVac(CVAC) - 2022 Q4 - Annual Report
2023-04-25 00:00
Exhibit 99.1 CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2022 and Provides Business Update · In 2022, ongoing business transformation driven by COVID-19 and flu clinical developments in collaboration with GSK and successful broadening of oncology footprint · Early 2023, strong validation of CureVac’s proprietary mRNA technology platform from positive preliminary Phase 1 data in COVID-19 and flu in collaboration with GSK o Monovalent modified COVID-19 candidate CV0501 demonstrate ...
CureVac(CVAC) - 2022 Q3 - Earnings Call Presentation
2022-11-17 05:34
Third Quarter and First Nine Months 2022 Financial Results and Business Update November 16, 2022 CureVac Speakers Interim Chief Development Officer | --- | --- | --- | --- | --- | --- | --- | --- | |---------------------------------------------|------------------|-------|-------|-------|-------|-------|-------| | Franz-Werner Haas \nChief Executive Officer | Business Update | | | | | | | | Ulrike Gnad-Vogt | Program Update | | | | | | | | | | | | | | | | | Ronald Plasterk | Program Update | | | | | | | | SV ...
CureVac(CVAC) - 2022 Q3 - Earnings Call Transcript
2022-11-17 05:33
Start Time: 09:00 January 1, 0000 10:01 AM ET CureVac N.V. (NASDAQ:CVAC) Q3 2022 Earnings Conference Call November 16, 2022, 09:00 AM ET Company Participants Franz-Werner Haas - CEO Pierre Kemula - CFO Ulrike Gnad-Vogt - Interim Chief Development Officer Ronald Plasterk - SVP Science & Innovation Sarah Fakih - VP Corporate Communications and IR Conference Call Participants Geoff Meacham - Bank of America Evan Wang - Guggenheim Jonathan Miller - Evercore Roy Buchanan - JMP Securities Zhiqiang Shu - Berenberg ...
CureVac(CVAC) - 2021 Q4 - Earnings Call Transcript
2022-04-29 03:26
CureVac NV (NASDAQ:CVAC) Q4 2021 Earnings Conference Call April 28, 2022 9:00 AM ET Company Participants Sarah Fakih - VP Corporate Communications & IR Franz-Werner Haas - CEO Klaus Edvardsen - Chief Development Officer Pierre Kemula - CFO Conference Call Participants Douglas Buchanan - JMP Securities Eun Yang - Jefferies Zhiqiang Shu - Berenberg Operator Greetings. Welcome to the CureVac Fourth Quarter and Full Year 2021 Financial Results and Business Update Conference Call. [Operator Instructions]. Please ...
CureVac(CVAC) - 2021 Q3 - Earnings Call Transcript
2021-11-20 07:05
CureVac N.V. (NASDAQ:CVAC) Q3 2021 Earnings Conference Call November 19, 2021 8:00 AM ET Company Participants Sarah Fakih – Vice President-Corporate Communications and Investor Relations Franz-Werner Haas – Chief Executive Officer Klaus Edvardsen – Chief Development Officer Pierre Kemula – Chief Financial Officer Mariola Fotin-Mleczek – Chief Technology Officer Conference Call Participants Manos Mastorakis – Deutsche Bank Evan Wang – Guggenheim Securities Jonathan Miller – Evercore ISI Zhiqiang Shu – Berenb ...